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Justificativa e Objetivos: A associação entre a formação de biofilme e resistência antifúngica foi sugerida 
por ser um fator importante na patogênese de diversas espécies de Candida. Além disso, estudos têm incluído 
candidíase invasiva de pacientes hospitalizados; no entanto, existem poucos estudos que avaliaram a distri-
buição das espécies, suscetibilidade aos antifúngicos e formação de biofilme de espécies de Candida isoladas 
de pacientes ambulatoriais. Assim, o objetivo deste estudo foi avaliar se a produção de biofilme contribui 
para a resistência antifúngica em Candida isoladas de amostras de urina obtidas de pacientes de ambulatório. 
Métodos: Durante um ano, 25 amostras de urina positivas para leveduras, foram coletadas, armazenadas e 
semeadas em ágar Sabouraud suplementado com cloranfenicol e deixadas a temperatura ambiente por 5 dias, 
para posterior identificação: 52% (13/25) foram C. albicans, 36% (9/25) C. tropicalis, 8% (2/25) C. krusei e 4% 
(1/25) C. parapsilosis. Resultados: A capacidade de formar biofilme foi detectada em 23 (92%) leveduras estu-
dadas. 15,4% (2/13) de C. albicans foram fluconazol (FLU) e cetoconazol (PET) resistente, enquanto que 11,1% 
(1/9) de C. tropicalis foram resistentes cetoconazol e foram anidulafungina (ANI) não-suscetíveis. Conclusão: 
Nossos resultados mostraram a alta capacidade de formação de biofilme entre espécies de Candida isoladas 
de pacientes ambulatoriais. 
Background and Objectives: the association between the biofilm formations an antifungal resistance has 
been suggested to be an important factor in the pathogenesis of several Candida species. Besides, studies 
have included invasive candidiasis from hospitalized patients; however there are few studies that evaluated 
the species distribution, antifungal susceptibility and biofilm formation of Candida species isolated from 
ambulatory patients. Thus, the aim of this study was to evaluate whether biofilm producing contributes to 
antifungal resistance in Candida isolates from urine sample obtained from ambulatory patients. Methods: 
During one year, 25 urine samples positive for yeast were collected, stored and plated on agar supplemented 
with chloramphenicol and Sabouread left at room temperature for 5 days for subsequent: 52% (13/25) were 
C. albicans, 36% (9/25) C. tropicalis, 8% (2/25) C. krusei and 4% (1/25) C. parapsilosis. Results: The ability to 
form biofilm was detected in 23 (92%) of the yeast studied and 15.4% (2/13) of C. albicans were fluconazole 
(FLU) and ketoconazole (KET) resistant, while 11.1% (1/9) of C. tropicalis were ketoconazole resistant and were 
anidulafungin (ANI) non-susceptible. Conclusion: our results showed the high capacity for biofilm formation 
among Candida isolates from ambulatory patients.
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Débora da Luz Becker, Danielly Joani Bulle, Paula Luttjohann Rodrigues, Odelta Dos Santos, Daiane Flores Dalla Lana, Alexandre Meneghello Fuentefria.
INTRODUTION
Candida biofilm is a yeasts population, as hyphae 
and pseudohyphae, growing on a biotic or abiotic 
surface, such as mucosal and medical devices, which is 
enclosed in an extracellular polymeric matrix forming a 
three-dimensional structure.1-3 Biofilms have been sug-
gested to be an important factor in the pathogenesis of 
several Candida species. Due to the biofilms thickness 
and density, and likely due to the metabolic state of the 
yeast, antifungal drugs are not very effective in eradicat-
ing yeast contained therein.4 Several other mechanisms 
are also proposed for increasing of antifungal resistance 
when the yeasts are in biofilm form such as: altered 
growth; presence of extracellular matrix with delayed 
penetration of the antimicrobial agent; expression of 
resistance genes and presence of persisters cells.5,6
The planktonic cell form is rarely found in human 
tissue, they are generally found in biofilm form in tissue, 
mucosal, implants, catheters and other surfaces, though.7  
Besides, it has recently been shown that the cells that 
detach from the biofilm have a greater association with 
mortality than equivalent planktonic yeasts.8 
In addition, in clinical laboratory routine, tools that 
allows biofilm cells antifungal resistance evaluation are 
not available, as a result only resistance profile of plankto-
nic forms are accessible to most laboratories. Therefore, 
studies involving both planktonic and biofilm forms, as 
well as, antifungal resistance are necessary to allow the 
use of direct therapy with greater specificity when the 
Candida isolates are capable of producing biofilms.9 
Candiduria is rarely present in healthy individuals; 
on the other hand it is a common clinical finding in hos-
pitalized patients, especially those in intensive care units 
(ICU), which often have multiple predisposing factors 
such as diabetes mellitus, prolonged exposure to antibio-
tics and the use of urinary catheters.10  Currently, there are 
no specific methods for differentiation between Candida 
infection and Candida colonization.11,12 In consequence, 
there are few studies that evaluated the Candida biofilm 
production and antifungal resistance from urine sample 
obtained from ambulatory patients, thus the pathogenic 
potential of yeast obtained from ambulatory patients 
remain unclear.
Fluconazole is preferred for the treatment of Can-
dida urinary tract infections (UTIs), because of its safety 
and achievement of high concentrations in the urine. 
Furthermore, it is less toxic than amphotericin B for the 
treatment of opportunistic infections by Candida. The 
main problem of the use of this drug is related to the 
intrinsic resistance of some Candida species such as C. 
glabrata and C. krusei, which limits its use in infections 
caused by these pathogens. The role of echinocandins 
and azoles that do not achieve measurable concentra-
tions in the urine is not clear; however there may be an 
alternative treatment.13,14 
The antifungal resistance has emerged as an im-
portant phenomenon becoming a therapeutic challenge 
worldwide. Besides, the limited numbers of clinical an-
tifungal agents can difficult candidiasis treatment. The 
increase of antifungal resistance has been associated to 
use of selective therapies with inadequate doses or the 
increasing use of prophylaxis drugs for yeast infections, 
which is likely to lead to the selection of clinical resis-
tance.15-17 Therefore, the aim of this study is to evaluate 
whether biofilm producing contributes to antifungal re-
sistance in Candida isolates from urine sample obtained 
from ambulatory patients.
METHODS
Isolates. A total of 25 yeasts were obtained from 
urine samples during a 1-year period (2011-2012). They 
were collected, consecutively, at the Laboratório de 
Análises Clínicas e Toxicológicas at Faculdade de Farmá-
cia and registered in the mycology collection of human 
pathogenic fungi of Federal University of Rio Grande do 
Sul and stored at -20ºC until they were used. 
This study was approved in the ethical committee 
of Federal University of Rio Grande do Sul number 18923 
(UFRGS/Brazil).
Isolation and identification. The yeasts were iso-
lated from urine samples when were seeded on the sur-
face of Sabouraud agar with 40 mg chloramphenicol l-1 
(SCA) and incubated at 37ºC in aerobic atmosphere until 
5 days. The colonies with yeast typical morphology in the 
SCA were identified at the species level using CHROMa-
gar Candida® medium, microculture and by automated 
systems using Vitek2 (BioMérieux, France). 
Antifungal agents and susceptibility test in 
planktonic cells. The following antifungal agents were 
tested: Fluconazole (FLU); Ketoconazole (KET); Miconazo-
le (MCZ); Anidulafungin (ANI) and Nystatin (NST). Stocks 
solutions were prepared and stored at -20°C until they we-
re used. Working solutions were prepared in RPMI-1640 
with L-glutamine, without bicarbonate (Gibco Invitrogen 
Corporation, USA) buffered with morpholinopropanosulfo-
nic acid (MOPS) 0.165 M at pH 7.0 (RPMI-MOPS) at 128 mg 
l-1 to FLU, 32 mg l-1 for KET and MCZ, 16 mg l-1 to ANI and 
512 mg l-1 to NST. 
The Minimal Inhibitory Concentration (MIC) values 
were determined in microplates by broth microdilution 
using the twofold dilution method according to the 
guidelines of the CLSI (Clinical and Laboratory Standards 
Institute, 2008), document M27-A3. The antifungal con-
centrations tested ranged from 0.125 to 64 µg l-1 for FLU, 
from 0.03 to 16 µg l-1 for KET and MCZ, from 0.016 to 8 
µg l-1 for ANI and from 0.5 to 256 µg l-1 for NST. Micro-
plates were incubated at 37ºC, and the results were read 
after 24-48h. Minimal Inhibitory Concentrations (MICs) 
were established for NST as the lowest concentration of 
antifungal agent which resulted in a complete inhibition 
of visible yeast growth, while for the azoles and ANI they 
were defined as the lowest concentration of antifungal 
agent that produced a 50% reduction in fungal growth 
when compared to the drug-free growth control one. 
The MIC was interpreted according to the break-
points suggested by document M27-A3 for FLU and KET. 
The breakpoints for MYC, ANI and NST were adapted 
Páginas 03 de 07
não para fins de citação
same procedure was performed with a catheter at zero 
time and the value of c.f.u (cm²)-1 was compared to the 
test value. All counts were made in duplicate and each 
experiment was repeated twice. 
Susceptibility test in recently detaches cells and 
post-biofilm cells. The susceptibility profile of yeasts 
recently detach from the biofilm and susceptibility profile 
of planktonic yeasts post-biofilm cells were performed as 
describe above to planktonic cells. For these assays were 
also only used strong biofilm producers isolates.  
Minimal biofilm eradication concentration 
(MBEC). For the strong biofilm yeasts it was determi-
ned the as described by Moskowitz et al. (2004) with 
modifications in the incubation time. The isolates were 
cultured in agar Sabouraud Dextrose for 24h at 37ºC and 
biofilm formation was performed as described above in 
materials and methods. The microplates were incubated 
for 48h at 37°C and cells not adhered were removed by 
washing with sterile saline. This procedure was preceded 
by the antifungal susceptibility test as described above 
by microdilution broth. The antifungal agent was remo-
ved and the plates were washed three times with sterile 
saline. Subsequent steps of fixation, staining and elution 
were performed as described in biofilm formation assay 
on polystyrene microplates. The minimum concentration 
of antifungal agent required to eradicate the biofilm was 
defined as MBEC. 
Statistical Analysis. The differences in the fre-
quency of the distinct genotypes to biofilm production 
and antimicrobial resistance were analysed using the c2 test 
and Person s´ correlations coefficients. All statistical analysis 
were performed in SPSS 18.0 (SPSS Inc., Chicago, IL, USA), 
and a p value <0.05 was considered statistically significant. 
RESULTS
To establish the resistance profile of planktonic ye-
ast obtained from urine sample from ambulatory patients 
twenty five Candida spp. isolated in the one year period 
of study were evaluated. The result of the analysis of the 
qualitative urine test showed the presence of leukocytes 
in all samples, while 32% (8/25) samples had counts 
above the reference value and 68% (17/25) had counts 
within the value considered normal. These isolates were 
identified at species level and then antifungal resistance 
and the biofilm formation ability were evaluated. Of the-
se 52% (13/25) were C. albicans, 36% (9/25) C. tropicalis, 
8% (2/25) C. krusei and 4% (1/25) C. parapsilosis. 
The susceptibility profiles of planktonic cells of 25 
yeasts isolated in this study are shown in Table 1. All C. 
krusei isolates were fluconazole and ketoconazole resis-
tant. When overall antifungal resistant was evaluated we 
observed that non-albicans Candida species were more 
resistant than C. albicans species with 50% (6/12) and 
30.8% (4/13), respectively. The high rate of antifungal 
resistant obtained in this study was related to azoles clas-
ses, when compared with others antifungal classes tested 
here, 32% (8/25) of azoles, 4% (1/25) of echinocandin and 
from Espinel-Ingroff and Cantón (2011), Ferrazza et al. 
(2005) and Isham and Ghannoum (2009). 
Control strains. Four strains from the American 
Type Culture Collection (ATCC) were used as controls: 
Candida albicans (24433), C. tropicalis (750), C. krusei 
(6258) and C. parapsilosis (22019).  
Biofilm formation assay on polystyrene micro-
plate. The initial screening of yeast biofilm producers 
were performed according to Crystal Violet method as 
previously described by Stepanović et al. (2007), with 
adaptations in the yeast growing time. Briefly, 20 µL of a 
suspension containing 1.5 x 106 cells ml-1 in sterile saline 
(0.85%) and 180 µL trypticase soy broth (TSB) medium 
(Oxoid; Basingstoke, UK) supplemented with 1% glucose 
added in flat-bottom 96-well microplates and incubated 
for 48h at 37ºC. To remove non-adherent cells, the wells 
were rinsed three times with sterile saline. The attached 
fungal were fixed with methanol for 20 min and dried 
for 30 min at room temperature. Crystal violet (0.5%) was 
used to stain the fungal for 15 min and dried for 15 min 
at room temperature. The biofilm was resuspended with 
ethanol for 30 min. The ab sorbance was measured at 570 
nm in a microtitre plate reader (Envision, Perkin Elmer). 
TSB was used as a negative control and Staphylococcus 
epidermidis (ATCC 35984) was used as a positive control, 
because it is considered to be a strong biofilm producer. 
The mean ab sorbance values and their standard devia-
tions (SD) were calculated. The average optical density 
(OD470) values were calculated for all tested yeast and 
negative con trols, performed in quadruplicate and 
repeated three times. All isolates were separated into 
categories using the O.D. measurement of bacterial films, 
as commonly used by Stepanovic et al., as follows: O.D. 
≤ O.D.c = no production of biofilm, O.D.c < O.D. ≤ (2x 
O.D.c) = weak production of biofilm, (2x O.D.c) < O.D. 
≤ (4x O.D.c) = moderate production of biofilm and (4x 
O.D.c) < O.D. = strong production of biofilm. The cut-off 
O.D. (O.D.c) was defined as three standard deviations 
above the mean O.D. of the negative control. 
Biofilm formation assay in catheter. The yeasts 
that were strong biofilm producers in the biofilm for-
mation assay on polystyrene microplate were used to 
determine its biofilm formation capacity in catheter. 
Firstly, the yeasts were growth in Sabouraud agar for 24h 
at 37°C, to obtain pure young colonies. After that, seven 
colonies were added to 2 ml of TSB and incubated for 24h 
at 37°C. The catheters (Foley Siliconized Latex - Rusch) 
were added to 99 ml of peptone water containing 1ml 
on the inoculum of TSB colonies and incubated for 96h 
at 37°C. Subsequent to incubation period, the catheters 
were washed three times with peptone water to remove 
the poorly adhered cells and were added 50 ml of pep-
tone water. The adhered cells were release of catheter by 
sonication with frequency of 40 KHz, for 10min. Water 
containing each sonicated catheter was submitted to 
decimal dilutions (10-1, 10-2 and 10-3) and 20 μl of each 
dilution were seeded in Sabouraud agar. The plates 
were incubated for 48h at 37°C and the numbers of c.f.u 
(cm²)-1 were determined. As an experiment control, the 
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(Fig. 1). In addition, to determine whether there are di-
fferences between antifungal concentration to eradicate 
planktonic cells and antifungal concentration to eradica-
te biofilm cells MIC was determinated to planktonic cells 
and MBEC to cells in biofilm. Theses assays showed that 
the antifungal concentration to eradicate cells in biofilm 
is higher when compared with the MIC from planktonic 
cell. Besides, the MBEC was higher than all antifungal 
concentration tested in all drugs studied.
Some differences were observed in antifungal sus-
ceptibly from post-biofilm cells, 8 isolates had high MIC 
value when compared with the MIC value of planktonic 
cells (Table 2). Furthermore, two isolates recently deta-
ched from biofilm (C. parapsilosis and C. tropicalis) be-
came fluconazole resistant. Interestingly, after successive 
cultivation, these isolates lowered the MIC value and 
became fluconazole sensitive again. 
none isolate was polyene class resistant.  
The MIC50% from FLU, KET, MCZ, ANI and NST to 
C. albicans were 1 µg ml-1, 0.0313 µg ml-1, 0.125 µg ml-1, 
0.0313 µg ml-1 and 2 µg ml-1, respectively and to C. tro-
picalis isolates were 2 µg ml-1, 0.0313 µg ml-1, 2 µg ml-1, 
0.0313 µg ml-1 and 2 µg ml-1, respectively. Of the 25 yeast 
studied herein, 92% (23/25) were biofilm producer and 
among theses 34.8% (8/23) were strong, 39.1% (9/23) 
were moderate and 26.1% (6/23) were weak biofilm 
producer. No association was detected between biofilm 
production and antifungal resistance (p=0.529). Among 
strong biofilm producer 75% (6/8) were C. tropicalis and 
12.5% (1/8) were C. albicans and C. parapsilosis. 
Biofilm produced in Foley urinary catheters were 
evaluated in all strong biofilm producers of Candida 
isolates and the results obtained showed that all Candida 
isolates were able to produce biofilm in urinary catheters 
Table 1. Susceptibility profile of 25 different yeast antifungal.
S: Susceptible, SDD: Susceptible dose-dependent, R: Resistant, NS: non-susceptible
Isolates (25)
C. albicans (13)
C. tropicalis (9)
C. krusei (2)
C. parapsilosis (1)
Fluconazole Ketoconazole Miconazole
S
10
9
0
1
S
10
7
1
1
S
13
8
0
0
SDD
1
0
0
0
SDD
1
1
1
0
SDD
0
1
0
1
Anidulafungin
S
13
8
2
1
NS
0
1
0
0
R
2
0
2
0
R
2
1
0
0
R
0
0
2
0
Nystatin
S
13
9
2
1
SDD
0
0
0
0
R
0
0
0
0
Table 2. Susceptibility profile of planktonic cells, biofilm cells and post-biofilm cells from 8 isolates of Candida spp.
*The results are demonstrate in µg ml-1; MIC = Minimal Inhibitory Concentration; MBEC = Minimal Biofilm Eradication Concentration; PBC = Post-biofilm Cell.
Isolates (25)
C. tropicalis (LEV1)
C. tropicalis (LEV4)
C. tropicalis (LEV10)
C. parapsilosis (LEV12)
C. tropicalis (LEV13)
C. tropicalis (LEV16)
C. albicans (LEV22)
C. tropicalis (LEV24)
Nystatin Anidulafungin Fluconazole Miconazole Ketoconazole
MIC*
2
2
2
1
2
2
2
2
MIC*
0.016
1
0.016
0.016
0.016
2
0.016
0.0313
MIC*
2
0.5
4
2
0.5
2
0.125
2
MIC*
0.0313
4
8
8
4
2
0.0313
2
MIC*
0.0313
0.0313
0.0313
0.0313
0.0625
0.0313
0.0313
0.0313
MBEC*
> 256
> 256
> 256
> 256
> 256
> 256
> 256
> 256
MBEC*
> 8
> 8
> 8
> 8
> 8
> 8
> 8
> 8
MBEC*
> 64
> 64
> 64
> 64
> 64
> 64
> 64
> 64
MBEC*
> 16
> 16
> 16
> 16
> 16
> 16
> 16
> 16
MBEC*
> 16
> 16
> 16
> 16
> 16
> 16
> 16
> 16
PBC*
4
2
2
2
4
2
2
2
PBC*
0.016
1
0.016
0.016
0.016
2
0.016
0.0313
PBC*
4
0.5
4
> 64
> 64
4
0.125
2
PBC*
0.5
4
8
8
4
2
0.0313
2
PBC*
0.0313
0.0313
0.0313
0.0313
0.0625
0.0313
0.0313
0.0313
Figure 1. Biofilm formation of Candida spp. isolates in urinary catheter.
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a potential issue with C. glabrata and C. krusei, because 
these species are intrinsically more resistant and develop 
further resistance during prolonged azole therapy, es-
pecially to fluconazole. This fact may be a problem for 
therapeutic and prophylactic strategies.25 
Echinocandins have remarkable in vitro activity 
against Candida spp., including azole-resistant isolates, 
in our results it was also observed, because all Candida 
isolates azole resistant were anidulafungin sensitive. 
Although some reports the reduced susceptibility or 
resistance to these Candida isolates antifungal.2,3,25 In this 
study, both C. albicans and non-albicans Candida species 
were susceptible to nystatin in vitro, which supports the 
use of nystatin for the treatment of Candida infections in 
the genitourinary tract. Additionally, when we compared 
the rates of resistance between C. albicans and non-albi-
cans Candida species, we also observed these rates were 
higher among non-albicans Candida species, this fact is 
a common characteristic among Candida infections.25 In 
this study, biofilm formation appears as a characteristic 
present in different yeasts species clinical isolates from 
urine sample of ambulatory patients. We found high 
number of isolates with capacity to form biofilm, 92% 
(23/25) of isolates were biofilm producer. These results 
are in accordance with previous studies which reported 
that many yeasts species were capable of producing bio-
films.16 When we classified the ability to form biofilm by 
species we found that C. tropicalis were strong biofilms 
producer, besides that, previous published results also 
demonstrate non-albicans Candida higher ability to form 
biofilm than C. albicans isolates.8 
Many authors have showed that there is a relation 
between biofilm formation and antifungal resistance, 
however when we analyzed the correlation between 
biofilm production from planktonic cells and antifungal 
resistance no significance difference was found.17 When 
we analyzed eight yeast isolates, which were strong bio-
film producer, in assay to biofilm producer in catheter, 
all isolates were able to produce biofilm in urinary cath-
eter. Moreover the cells in biofilm, on microplates, were 
increasing MIC, thus the biofilm is an important factor in 
antifungal resistance, because when the yeast was in biofilm 
the antifungal drugs are not very effective in eradicating 
yeast contained therein as previously reported.4 
To try elucidating to role of biofilm in antifungal 
resistance we compared the results obtained to MIC 
and MBEC, although we found no association between 
antifungal resistance and biofilm formation, MBEC was 
higher than MIC in planktonic cells. In consequence, 
these results suggest that biofilm could be an important 
factor in the antifungal resistance.17 
The post-biofilm cells were tested and it was pos-
sible to observe that the MIC was higher in two species 
non-albicans Candida (C. tropicalis and C. parapsilosis) 
than planktonic cells to fluconazole. Other interesting 
results observed were that cells recently detached from 
biofilm showed higher MIC value, however after some 
passages in culture medium the MIC returned to value 
obtained when the planktonic cells were tested. Recent 
DISCUSSION 
In this study were identified yeasts at specie level, 
analyzed the ability to form biofilm and the antifungal 
resistance profile from planktonic and biofilm cells of 
Candida isolated from urine sample from ambulatory 
patients. The identification at the specie level showed 
that more prevalent species were C. albicans followed 
of C. tropicalis; in others studies the C. albicans has also 
been described as more prevalent specie isolated from 
urine sample.18,19 Besides, C. albicans was the most pre-
valent in candiduria other non-albicans Candida species 
have become emerging isolates.20 We also found some 
non-albicans Candida species in the urine sample from 
ambulatory patients, these data are in agreement with pre-
vious studies that described the high rate of non-albicans 
Candida invasive in patients from critical units. However, 
the epidemiological changes have also been detected in 
patients from community this phenomenon is important 
because the ambulatory patient, with superficial infec-
tions, may represent reservoirs of invasive fungal infec-
tions. Thus, fungal infections from ambulatory patients 
could be underestimated especially because sometimes 
there are no specific methods for differentiation between 
yeast infection and yeast colonization. Besides, some 
authors have described the importance of monitoring 
fungal infection in ambulatory patients which may lead 
to an invasive infection if opportunistic infection condi-
tions occur.21 
There are not specific methods for differentiation 
between Candida infection and Candida colonization 
we studied urine sample from ambulatory patients and 
it was difficult to determinate whether the patient was 
colonized or infected by yeasts. Then, we tried to analyze 
the number of leukocytes in the urine, however the re-
sults were inconclusive.22 
When we evaluated the susceptibility profile of 
planktonic yeast we found low rates of antifungal resis-
tance among twenty five isolates studied. These results 
agreed with rates previously published about candiduria 
nosocomial, when was found low rates of antifungal 
resistance to amphotericin B, fluconazole, voriconazole 
and caspofungin.23 In opposite, others studies found high 
rate of antifungal resistant to Candida species obtained 
from urine samples from patients in intensive care unit 
and patients with candiduria.24,25 In our study, when we 
tested the azole compounds we found two C. albicans 
fluconazole and ketoconazole resistant. Two C. krusei 
isolates, as expected, were resistant to fluconazole, its 
isolates were also miconazole resistant. One C. tropicalis 
isolate was ketoconazole resistant and one was anidu-
lafungin non susceptible. On the other hand, all isolates 
tested were sensitive to nystatin. Consequently, we ob-
tained a high rate of antifungal resistant to azoles classes, 
when compared with others antifungal classes we tested 
in accordance to previous data published that also de-
scribed high level of resistance to azoles in patients with 
candiduria.24 In this context, resistance to azoles could 
represent ambulatory reservoir of invasive fungal infec-
tion and resistant isolates. In addition, azole resistance is 
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13. Achkar JM, Fries BC. Candida infections of the genitourinary 
tract. Clin Microbiol Rev 2010;23(2):253-73. doi: 10.1128/
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Rev Soc Bras Med Trop 2010;43(5):575-9. doi: 10.1590/S0037-
86822010000500021
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Candida albicans and Candida tropicalis adherence to various 
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16. Achkar JM, Fries BC. Candida infections of the genitourinary 
tract. Clin Microbiol Rev 2010;23(2):253-73. doi: 10.1128/
CMR.00076-09
17. Ramage G, Rajendran R, Sherry L, et al. Fungal biofilm resistance. 
Int J Microbiol 2012;2012:528521. doi: 10.1155/2012/528521
18. Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current 
epidemiology, pathogenicity, biofilm formation, natural 
antifungal products and new therapeutic options. J Med 
Microbiol 2013;62(Pt1):10-24. doi: 10.1099/jmm.0.045054-0
19. Kauffman CA, Vazquez JA, Sobel JD,  et al. Prospective 
studies reported a more considerable association betwe-
en the cells that detach from biofilm and mortality than 
equivalent planktonic yeasts.12 These results confirm that 
biofilm formation is a complex system and when the 
cells are in biofilm they became high pathogenic than 
planktonic cells, thus is necessary to evaluate mainly 
antifungal resistance of biofilm forms. 
Biofilms of Candida can be formed quickly on plas-
tic surfaces as Foley catheters and intrauterine devices.16 
Previous studies have been shown that the use of  Foley 
catheter is associated with candiduria, once the catheter 
serves as an entry of microorganisms in the urinary sys-
tems.9,10 Among patients undergoing catheterization in 
the short term, i.e up to seven days, 50% of them may 
developed infections; while all patients undergoing 
long-term catheterization, longer than 28 days, will be 
likely to develop urinary infection.11 Our results showed 
that all tested yeasts are able to biofilm production in 
urinary catheter in a period of 96h. The high ability of 
biofilm formation of this genus is confirmed by both the 
data observed in this study and the literature. 
In conclusion, our results showed the high capa-
city for biofilm formation among Candida isolates from 
ambulatory patients. When we analyzed the relation 
between antifungal resistance and biofilm formation 
from planktonic cells we did not find any significant 
association. However, our results point to the relation 
of biofilm in higher rates of MBEC and higher MIC value 
from post-biofilm cells, these results suggest that cells 
in biofilm are resistant to high dose of antifungal i.e 
above the therapeutic dose usually used. Thus, our re-
sults demonstrate the importance of a correct choice of 
antifungal therapy for the treatment of biofilm infections, 
as well as, the need, in routine clinical laboratory, of tools 
that determine specific susceptibility tests for cells in bio-
film, as the susceptibility test based on MIC values alone 
cannot accurately determine the exact susceptibility of 
fungal in biofilm. 
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